1naresh2naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) [cf920c0d-e476-494f-a88a-d6c8c3fcbe50] => Array ( [runtime-id] => cf920c0d-e476-494f-a88a-d6c8c3fcbe50 [type] => toll-free-key [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [4b93de7b-6a7b-4212-a726-6b71eb96584f] => Array ( [runtime-id] => 4b93de7b-6a7b-4212-a726-6b71eb96584f [type] => toll-free-key ) ) [credentials] => Array ( [method] => toll-free-key [value] => tf_ipsecsha;4bece207dddc76617b4267fc6847f646e5cd57ec ) ) ) 1naresh2nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) [cf920c0d-e476-494f-a88a-d6c8c3fcbe50] => Array ( [runtime-id] => cf920c0d-e476-494f-a88a-d6c8c3fcbe50 [type] => toll-free-key [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [4b93de7b-6a7b-4212-a726-6b71eb96584f] => Array ( [runtime-id] => 4b93de7b-6a7b-4212-a726-6b71eb96584f [type] => toll-free-key ) ) [credentials] => Array ( [method] => toll-free-key [value] => tf_ipsecsha;4bece207dddc76617b4267fc6847f646e5cd57ec ) ) )Table 2:Results of univariate analysis looking at any complication (transient or permanent neurologic deficit) during embolization*
Criteria Odds Ratio (95% CI) P value Male Gender 0.80 (0.38–1.69) .56 Presenting Symptom Hemorrhage 0.96 (0.42–2.23) .93 Seizure 0.68 (0.30–1.52) .35 Headache 0.71 (0.23–2.19) .55 Neurologic deficit 1.90 (0.76–4.73) .17 Incidental finding 1.82 (0.46–7.23) .40 mRS score at diagnosis 0–2 0.90 (0.28–2.88) .86 3–5 1.11 (0.35–3.52) .86 AVM Features Eloquent cortex involved 1.48 (0.57–3.84) .43 Deep venous drainage 1.07 (0.5–2.3) .86 Spetzler-Martin grade I and II 1.50 (0.15–15.46) .73 III 0.64 (0.07–6.14) .69 IV 1.09 (0.11–10.35) .94 V 1.88 (0.19–18.32) .59 Basal ganglia location 2.11 (0.88–6.10) .09 Nidal volume reduction (%) 0–24 0.03 (−0.77–0.83) .96 25–49 −0.19 (−0.63–0.25) .65 50–74 −0.19 (−0.59–0.21) .63 >74 0.35 (−0.04–0.74) .37 Number of embolization sessions 1 0.09 (−0.34–0.52) .82 2 −0.61 (−1.06–0.16) .18 3 0.23 (−0.22–0.68) .61 4+ 0.31 (−0.11–0.73) .46 Number of pedicles embolized 1 −0.33 (−0.68–0.02) .34 2 0.29 (−0.05–0.63) .38 3+ 0.14 (−0.28–0.56) .73
Note:—CI indicates confidence interval.
* All data reflect complication rates per patient (n = 192), except for number of pedicles embolized, which reflects rates per session (n = 489).